We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$231B
AUM Growth
+$33B
Cap. Flow
+$7.99B
Cap. Flow %
3.46%
Top 10 Hldgs %
20.51%
Holding
6,891
New
816
Increased
2,304
Reduced
2,388
Closed
883

Sector Composition

Rank Sector Weight
1 Technology 8.34%
2 Healthcare 6.09%
3 Financials 5%
4 Consumer Discretionary 4.53%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
5976
CALL
AstraZeneca
AZN
$258B
-316,750
Closed -$42.9M
AZTR icon
5977
Azitra
AZTR
$7.84M
-112
Closed -$33.6K
BALL icon
5978
CALL
Ball Corp
BALL
$17B
-7,600
Closed -$378K
BALY icon
5979
Bally's
BALY
$500M
-20,819
Closed -$273K
BATL icon
5980
Battalion Oil
BATL
$75.6M
-11,642
Closed -$71.9K
BAX icon
5981
PUT
Baxter International
BAX
$13.5B
-70,000
Closed -$2.64M
BBDC icon
5982
Barings BDC
BBDC
$985M
-353,668
Closed -$3.15M
BBEU icon
5983
JPMorgan BetaBuilders Europe ETF
BBEU
$9.55B
-5,500
Closed -$280K
BBWI icon
5984
CALL
Bath & Body Works
BBWI
$3.86B
-50,000
Closed -$1.69M
BC icon
5985
Brunswick
BC
$5.25B
-43,143
Closed -$3.41M
BCAT icon
5986
BlackRock Capital Allocation Term Trust
BCAT
$1.65B
-21,870
Closed -$317K
BCBP icon
5987
BCB Bancorp
BCBP
$157M
-46,747
Closed -$521K
BCLI
5988
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-11,700
Closed -$35.1K
BE icon
5989
PUT
Bloom Energy
BE
$60.5B
-34,800
Closed -$461K
BELFB
5990
Bel Fuse Inc Class B
BELFB
$3.59B
-26,546
Closed -$1.27M
BFAM icon
5991
Bright Horizons
BFAM
$3.61B
-12,925
Closed -$1.05M
BF.B icon
5992
PUT
Brown-Forman Class B
BF.B
$13.2B
-150,000
Closed -$8.65M
BFST icon
5993
Business First Bancshares
BFST
$1.02B
-32,189
Closed -$604K
BH.A icon
5994
Biglari Holdings Class A
BH.A
$1.25B
-710
Closed -$595K
BHC icon
5995
CALL
Bausch Health
BHC
$2.45B
-428,800
Closed -$3.52M
BHP icon
5996
BHP
BHP
$246B
-441,084
Closed -$26.6M
BHVN icon
5997
Biohaven
BHVN
$2.07B
-44,169
Closed -$1.37M
CMRC
5998
Commerce.com Inc Series 1
CMRC
$186M
-185,886
Closed -$1.83M
BIRD icon
5999
Smartbird Inc
BIRD
$29.4M
-2,853
Closed -$63.3K
BIZD icon
6000
VanEck BDC Income ETF
BIZD
$1.71B
-134,393
Closed -$2.15M

Similar funds

Israel Englander's Q4 2023 Portfolio in Review

As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Israel Englander deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.

  • Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
  • Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
  • Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
  • Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
  • Israel Englander opened 816 new positions and closed 883 in Q4 2023.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.